(Q42279126)

English

Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.

scientific article published on 14 January 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

chronic hepatitis B

1 reference

based on heuristic

inferred from title

Antonio D'Avolio

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Valeria Ghisetti

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Lucio Boglione

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Giuseppe Cariti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Gabriella Gregori

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Elisa Burdino

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Lorena Baietto

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Francesco G De Rosa

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Giovanni Di Perri

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

14 January 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Liver International

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

580-585

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

EASL Clinical Practice Guidelines: management of chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Surrogate end points and long-term outcome in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Predictors of treatment response in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Sustained HBs seroconversion during lamivudine and adefovir dipivoxil combination therapy for lamivudine failure.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Correlation of serum hepatitis B surface antigen level with response to entecavir in naïve patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Early serum HBsAg drop: A strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Serum HBsAg Decline During Long-term Potent Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B and Prediction of HBsAg Loss

1 reference

https://api.crossref.org/works/10.1111%2FLIV.12091

21 January 2018

Identifiers

10.1111/LIV.12091

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23311449%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42279126&oldid=1569066302"